+ 1 303 249 9174
FloydTaub@a-i-gene.com

News and Events

American Association for Cancer Research

aiGENE is proud to announce our April 2025 AACR poster :

April 2025

Trans-renal DNA : Urine liquid biopsies methodology to increase compliance, convenience, and yield of systemic cfDNA

American Association for Cancer Research

aiGENE is proud to announce our November 2024 AACR poster :

November 2024

cfDNA Collection and Purification Improved and Simplified

American Association for Cancer Research

Simplified selective electrochemical detection of ctDNA differentiates between cancer progression and regression

March 2024

Abstract 5027: Simplified selective electrochemical detection of ctDNA differentiates between cancer progression and regression

American Association for Cancer Research

aiGENE is proud to announce our April 2024 AACR poster :

April 2024

Simplified RAPID Selective Electrochemical Detection of ctDNA Differentiates ​Between Cancer Progression and Regression

5280 Magazine

5280 - The Best Cancer Care in Colorado Keeps Getting Better

August 2023

Colorado doctors and researchers are pioneering advancements that have us closer than ever to finding a cure.

The Colorado Sun

The Colorado Sun

June 2023

What’s Working: Where a company that develops cancer tests, other startups are finding funding in Colorado

DOD Air Force SBIR

Air Force SBIR award

May 2023

aiGENE is proud to announce to our partnership with the Department of the Air Force Material Command’s competitive awards-based Small Business Innovation Research (SBIR) program

Colorado Office of Economic Development and International Trade

Colorado OEDIT Early-Stage Capital and Retention Grant

May 2023

aiGENE has been awarded an Early-Stage Capital and Retention grant through OEDIT’s Advanced Industries Accelerator Program.

Genome Web Article

Genome Web

April 2023

AiGene Aims to Remodel Clinical Trials With ctDNA Tech for On-Treatment Response Monitoring (opens PDF)  
GenomeWeb direct link (requires login)

Pittsburgh Conference

Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy

March 2023

Dr. Matt Russo from Henry Lab in collaboration with aiGENE presented Electrochemical Biosensor for Point of Care based Monitoring of Cancer Progression using ctDNA Methylscape as a Biomarker

MedRXiv

MedRXiv

February 2023

Novel "SMARTer" Clinical Trial Design Improves Odds of Approval and Can Reduce Study Size By Over 80%: Modeling Use of a ctDNA "Optimizing Diagnostic" for Early Therapy Switching in Immuno-Oncology Trials. QR code to article

aiGENE Press Release for AACR

Press Release RE: American Association for Cancer Research

November 2022

Is a hand-held cancer meter feasible?

American Association for Cancer Research

American Association for Cancer Research Conference: PRECISION PREVENTION, EARLY DETECTION, AND INTERCEPTION OF CANCER

November 2022

A simplified, potentially point-of-care (POC), electrode method detects changes in the amount of cfDNA/ctDNA and evaluates the response of advanced cancer patients to therapy

Colorado Office of Economic Development and International Trade

Colorado Office of Economic Development and International Trade Center

May 2021

OEDIT Proof of Concept Award

University of Queensland

University of Queensland Australia UQ News

July 2020

License agreement creates golden opportunity for cancer diagnostic technology